We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current NERV market cap is 10.14M. The company's latest EPS is USD 0.2058 and P/E is 6.75.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.17M | -6.68M | -6.28M | -4.37M | -4.52M |
| Net Income | -9.02M | -8.57M | -8.23M | 22.51M | -4.27M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 41.18M | 0 | 0 | 0 | 0 |
| Operating Income | 1.85M | -45.37M | -25.23M | -23.12M | -21.85M |
| Net Income | 1.94M | -49.91M | -32.11M | -30.01M | 1.44M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 56.9M | 50.51M | 46.29M | 42.81M | 37.14M |
| Total Liabilities | 85.36M | 87.1M | 90.78M | 64.48M | 62.84M |
| Total Equity | -28.46M | -36.59M | -44.49M | -21.67M | -25.69M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 57.63M | 77.12M | 55.09M | 56.9M | 37.14M |
| Total Liabilities | 4.96M | 69.15M | 75.11M | 85.36M | 62.84M |
| Total Equity | 52.66M | 7.98M | -20.02M | -28.46M | -25.69M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -14.79M | -6.1M | -10.03M | -14.38M | -19.55M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 19.6M | N/A | N/A | N/A | N/A |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -33.82M | -24.6M | -24.65M | -14.79M | -19.55M |
| Investing | 24.53M | N/A | -16k | N/A | N/A |
| Financing | 13.24M | 60M | N/A | 19.6M | N/A |
| Market Cap | 10.14M |
| Price to Earnings Ratio | 6.75 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.46 |
| Price to Book Ratio | -0.38 |
| Dividend Yield | - |
| Shares Outstanding | 6.99M |
| Average Volume (1 week) | 10.86k |
| Average Volume (1 Month) | 6.9k |
| 52 Week Change | -42.00% |
| 52 Week High | 3.69 |
| 52 Week Low | 1.15 |
| Spread (Intraday) | 0.03 (2.08%) |
| Company Name | Minerva Neurosciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.minervaneurosciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
